Complete Up To Date Information about Enacard Tablets For Dogs.
NADA Number: 141-015 | |
| Proprietary Name |
Enacard® Tablets For Dogs Enacard® |
|---|---|
| Sponsor |
Merial Ltd. |
| Sponsor Address |
3239 Satellite Blvd. Bldg. 500 Duluth, GA 30096-4640 USA |
| Ingredients |
Enalapril Maleate |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Per Os |
| Dose Form |
Tablet |
| Drug Form |
Tablet |
| Dispensing Status |
RX |
| Patent Number |
4374829 |
| Exclusivity |
No active ingredient of the drug has been previously approved in any other application. |
|
Dosage Amount, Indications & Limitations |
520.804 Enalapril tablets. Specifications: Each tablet contains either 1.0, 2.5, 5.0, 10.0, or 20.0 milligrams of enalapril maleate. Conditions of use: Dogs Amount: 0.5 to 1.0 milligram of enalapril maleate per kilogram of body weight per day. Indications: Treatment of mild, moderate, and severe (modified New York Heart Association Class II, III, IV) heart failure in dogs. Limitations: Use 0.5 milligram per kilogram once daily. In the absence of adequate clinical response within a 2-week period, use may be increased to twice daily (a total of 1.0 milligram per kilogram). Enalapril maleate is administered as conjunctive therapy with furosemide and digoxin in the treatment of dilated cardiomyopathy and furosemide with or without digoxin in the treatment of chronic valvular disease. The safety of enalapril for use in breeding dogs has not been established. Use in pregnant bitches is not recommended. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |